Cargando…
SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration
OBJECTIVE: Economic evaluations in wet age-related macular degeneration (ARMD) is hampered as often utility values for solely one eye are used, mostly the better-seeing eye (BSE). Moreover, frequently chosen methods rely on patient values and/or disease specific measures, while economic evaluations...
Autores principales: | Visser, Martijn S., Amarakoon, Sankha, Missotten, Tom, Timman, Reinier, Busschbach, Jan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321468/ https://www.ncbi.nlm.nih.gov/pubmed/28225799 http://dx.doi.org/10.1371/journal.pone.0169816 |
Ejemplares similares
-
Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial
por: Visser, Martijn S., et al.
Publicado: (2020) -
Is LEA symbol better compared to Snellen chart for visual acuity assessment in preschool children?
por: Vivekanand, Undrakonda, et al.
Publicado: (2019) -
The impact of a better-seeing eye and a worse-seeing eye on vision-related quality of life
por: Hirneiss, Christoph
Publicado: (2014) -
A very short version of the Visual Function Questionnaire (VFQ‐3oo7) for use as a routinely applied Patient‐Reported Outcome Measure
por: Visser, Martijn S., et al.
Publicado: (2020) -
HAS SNELLEN CHART LOST THE BATTLE TO ETDRS IN CATARACT SURGERY VISUAL ACUITY EVALUATION?
por: Petrović Pajić, Sanja, et al.
Publicado: (2021)